TXG

52.7508.07%
JR

John R. Stuelpnagel

Independent Chairman

Dr. John R. Stuelpnagel, DVM, MBA. serves as an Advisor at Venrock Management, LLC since October 2020. Dr. Stuelpnagel joined Venrock family in 1998. Dr. Stuelpnagel is a Co-Founder and serves as the Chairman of the Board of Fabric Genomics, Inc. Dr. Stuelpnagel serves as an Advisor of Ariosa Diagnostics, Inc. Dr. Stuelpnagel was Chairman of the Board of Directors for Element Biosciences, Inc. since September 2017 until 2023. He co-founded Ariosa Diagnostics, Inc. and served as its Executive Chairman from May 2010 to 2015. He served as an Associate of CW Group, Inc. from June 1997 to September 1998. Dr. Stuelpnagel co-founded and held senior leadership roles in several life science companies where he has an extensive knowledge in building successful enterprises and commercializing disruptive technologies. He served as Venture Capitalist at CW Group. He co-founded Illumina Inc. in 1998 and served as its Senior Vice President of Operations since April 1998. He served as the Chief Operating Officer of Illumina Inc. from January 2005 to April 2008. At Illumina, he served as Senior Vice President since April 2002, Vice President of Business Development from October 1999 to April 2002, Acting President and Chief Executive Officer from April 1998 to October 1999. He served as General Manager of Illumina’s Microarray business from February 2007 to April 2008 and also served as its Acting Chief Financial Officer until April 2000. Dr. Stuelpnagel served as an Associate of Catalyst Partners, Inc. from August 1996 to June 1997. He served as an Associate of CW Ventures III, L.P. He has been the Chairman of the Board of Inscripta, Inc. (formerly Muse Biotechnology, Inc.) since March 2017. He has been a Director of Encoded Therapeutics, Inc. since May 2017. He has been the Independent Chairman of 10X Genomics, Inc. since August 2013 and serves as its Director. He served as the Chairman of the Board of Sequenta, Inc. from 2010 to 2015. He served as Director at Adaptive Biotechnologies Corporation. He served as a Director of Sequenta, Inc. He served as a Director of Illumina Inc. from April 1998 to April 2008. He served as a Director at Ariosa Diagnostics, Inc. since December 2009. He serves as Director of Federation Bio Inc. Dr. Stuelpnagel has B.S. in Biochemistry from University of California, Davis from 1975 to 1979, Doctorate in Veterinary Medicine from University of California, Davis from 1979 to 1983, M.B.A. from University of California, Los Angeles from 1995 to 1997.

Positions